We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$24.2B
AUM Growth
+$135M
Cap. Flow
-$994M
Cap. Flow %
-4.11%
Top 10 Hldgs %
6.14%
Holding
1,837
New
161
Increased
558
Reduced
861
Closed
176

Top Buys

Rank Stock Value
1
OPLN
Openlane
OPLN
+$80.2M
2
BMS
Bemis
BMS
+$73.6M
3
KIM icon
Kimco Realty
KIM
+$69M
4
PM icon
Philip Morris
PM
+$65.9M
5
KO icon
Coca-Cola
KO
+$58.6M

Sector Composition

Rank Sector Weight
1 Financials 16.19%
2 Industrials 14.18%
3 Technology 13.31%
4 Consumer Discretionary 10.56%
5 Healthcare 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEMP
1601
DELISTED
Cempra, Inc.
CEMP
$13K ﹤0.01%
753
+57
+8% +$1.03K
ACAD icon
1602
Acadia Pharmaceuticals
ACAD
$4.9B
$12K ﹤0.01%
434
+32
+8% +$698
RPT
1603
Rithm Property Trust
RPT
$93.3M
$12K ﹤0.01%
185
-8,521
-98% -$535K
ANAC
1604
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$12K ﹤0.01%
224
+17
+8% +$1.25K
CRIS icon
1605
Curis
CRIS
$8.81M
$11K ﹤0.01%
3
WPM icon
1606
Wheaton Precious Metals
WPM
$55.4B
$11K ﹤0.01%
698
ADMS
1607
DELISTED
Adamas Pharmaceuticals
ADMS
$11K ﹤0.01%
756
+59
+8% +$994
FLXN
1608
DELISTED
Flexion Therapeutics, Inc.
FLXN
$11K ﹤0.01%
1,189
+93
+8% +$1.13K
FOMX
1609
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$11K ﹤0.01%
1,690
+132
+8% +$851
KERX
1610
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$11K ﹤0.01%
2,392
+187
+8% +$746
BLUE
1611
DELISTED
bluebird bio
BLUE
$10K ﹤0.01%
18
+2
+13% +$1.23K
FTNT icon
1612
Fortinet
FTNT
$121B
$10K ﹤0.01%
1,565
-2,380,005
-100% -$13.1M
KDNY
1613
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$9K ﹤0.01%
+146
New +$11.8K
CLDX icon
1614
Celldex Therapeutics
CLDX
$3.15B
$5K ﹤0.01%
89
+7
+9% +$788
RLYP
1615
DELISTED
RELYPSA INC COM
RLYP
$5K ﹤0.01%
397
+30
+8% +$510
CRC
1616
DELISTED
California Resources Corporation
CRC
$5K ﹤0.01%
+501
New +$5.91K
ESPR
1617
DELISTED
Esperion Therapeutics
ESPR
$4K ﹤0.01%
237
+18
+8% +$290
EXAS
1618
DELISTED
Exact Sciences
EXAS
$4K ﹤0.01%
534
+42
+9% +$269
CLVS
1619
DELISTED
Clovis Oncology, Inc.
CLVS
$3K ﹤0.01%
157
+13
+9% +$275
TTPH
1620
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$3K ﹤0.01%
31
+3
+11% +$300
NVTR
1621
DELISTED
Nuvectra Corporation Common Stock
NVTR
$3K ﹤0.01%
+616
New +$3.31K
AAT
1622
American Assets Trust
AAT
$1.41B
-2,641
Closed -$101K
ABCB icon
1623
Ameris Bancorp
ABCB
$6B
-3,737
Closed -$127K
ADC icon
1624
Agree Realty
ADC
$9.41B
-3,951
Closed -$134K
AGX icon
1625
Argan
AGX
$8.6B
-1,674
Closed -$54K

Similar funds

Victory Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Victory Capital Management held 1,837 positions worth $24.2B, up 0.56% from $24.1B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Victory Capital Management withdrew a net $994M in Q1 2016, closing 176 positions and reducing 861 holdings. Its most notable exit was Ingram Micro, an estimated $44M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Victory Capital Management opened a new position in Bemis worth $79.1M.

  • Victory Capital Management's largest Q1 2016 buy was Bemis: 1,527,171 shares worth $79.1M.
  • Victory Capital Management added most to Openlane in Q1 2016, an estimated $80.2M increase.
  • Victory Capital Management's biggest Q1 2016 reduction was Marriott International, cutting an estimated $93.4M.
  • Victory Capital Management fully exited Ingram Micro in Q1 2016, selling an estimated $44M.
  • Victory Capital Management's ten largest holdings make up 6.1% of its $24.2B portfolio in Q1 2016.
  • Victory Capital Management opened 161 new positions and closed 176 in Q1 2016.
  • Victory Capital Management's portfolio value rose 0.56% quarter-over-quarter to $24.2B.

Based on Victory Capital Management's 13F filing for Q1 2016, filed 12 May 2016.